Buy & Sell Apellis Pharmaceuticals Inc (APLS) – Apellis Pharmaceuticals Inc Price Today
Key Stats
- $5.25BMarket Cap
- HealthSector
- -10.07%3M Drawdown
- $5.32BEnterprise Value
- -Dividend Yield
- 12 daysTypical Hold Time
Apellis Pharmaceuticals Inc (APLS) is currently valued at a market capitalization of $5.25B, with an enterprise value of $5.32B. Over the past 52 weeks, Apellis Pharmaceuticals Inc has traded between a low of $16.93 and a high of $41.12, highlighting its annual price range. Over the past three months, Apellis Pharmaceuticals Inc has recorded a drawdown of -10.07%, reflecting recent price volatility. On average, investors hold Apellis Pharmaceuticals Inc for approximately 12 days, indicating typical investor behavior on the platform.
About Apellis Pharmaceuticals Inc
Apellis Pharmaceuticals is a biopharmaceutical company focused on complement science. It develops therapies for serious diseases, including the first-ever treatment for geographic atrophy, a leading cause of blindness.
Most Recent News
SpaceX IPO raises $75B, sparking potential tech IPO wave including Anthropic, OpenAI, and Stripe.
SpaceX recently launched its IPO, raising $75 billion and reaching a market cap over $2.1 trillion. This major event could trigger a wave of tech IPOs from companies like Anthropic, OpenAI, Anduril, Databricks, and Stripe. Anthropic and OpenAI have f...

GoDaddy shareholders urged to join class action over alleged misleading business info
The Rosen Law Firm has announced an investigation and class action lawsuit on behalf of GoDaddy Inc. shareholders who may have suffered losses due to allegedly misleading business information released by the company. Investors who purchased GoDaddy s...

XM enhances trading platform with new features and Partner Code 274PQ for global users.
XM, an international online trading platform, announced improvements in technology, educational resources, and user accessibility to support global traders. The platform offers multiple trading options including MetaTrader 4 and 5, along with mobile ...
